✦ LIBER ✦

8046 Preliminary results of the ENDORAD trial: RAD001 (everolimus) monotherapy as second-line or third-line treatment of endometrial carcinoma: a phase II trial of GINECO group

✍ Scribed by Ray-Coquard, I.; Mayer, F.; Weber, B.; Becuwe, C.; Bougnoux, P.; Fabbro, M.; Floquet, A.; Joly, F.; Paraiso, D.; Pujade-Lauraine, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus as second- or third-line trea

✍ Ray-Coquard, I; Favier, L; Weber, B; Roemer-Becuwe, C; Bougnoux, P; Fabbro, M; F 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 271 KB

Second-line treatment of non-small cell

✍ Papadakis, E; Kourousis, Ch; Androulakis, N; Agelaki, S; Apostolopoulou, F; Pala 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Hexamethylmelamine as first-line chemoth

✍ JT Thigpen; JA Blessing; H Ball; P Hanjani; A Manetta; H Homesley 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Hexamethylmelamine as first-line chemoth

✍ J. Tate Thigpen; John A. Blessing; Harrison Ball; Parviz Hanjani; Alberto Manett 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 231 KB

A phase II trial of a selective c-Met in

✍ Kang, Yoon-Koo; Muro, Kei; Ryu, Min-Hee; Yasui, Hirofumi; Nishina, Tomohiro; Ryo 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 234 KB

Phase II Trial of 5-Fluorouracil/Leucovo

✍ Alex Y. Chang; Gilberto Lopes; Koo Wen Hsin; Robert Lim; Foo Kian Fong; John Won 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 100 KB